Clinical case of torpid course of metastatic triple negative breast cancer

QR Code

Clinical case of torpid course of metastatic triple negative breast cancer

Background. Breast cancer is the most common cancer and the leading cause of cancer death in women worldwide. The presence of an unfavorable molecular biological subtype significantly worsens the prognosis, making it necessary to individualize treatment strategy for each patient.The aim of the study...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. P. Kulikov, E. Yu. Golovkin, S. A. Mertsalov, I. I. Vinogradov, M. V. Borisova, S. Kh. Vagapova
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2022-03-01
Series:	Сибирский онкологический журнал
Subjects:	breast cancer triple-negative breast cancer recurrent breast cancer combined modality treatment
Online Access:	https://www.siboncoj.ru/jour/article/view/2038
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

c-MYC Levels and Metabolic Parameters in Triple-Positive and Triple-Negative Breast Cancer
by: Doaa N. Abood, et al.
Published: (2025-06-01)

Case Report: Palliative Care for Metastatic triple negative Breast Cancer with Cutaneous Involvement
by: Kaylee Scarnati, et al.
Published: (2025-06-01)

IQGAP1 is a Specific Target of Haldol in Triple Negative Breast Cancer
by: Mahmood Meqdad
Published: (2025-06-01)

The Role of Genomics and Transcriptomics in Characterizing and Predicting Patient Response to Treatment in Triple Negative Breast Cancer (TNBC)
by: Franklin Eduardo Corea-Dilbert, et al.
Published: (2025-04-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)

Role of Glucocorticoid Receptor in Triple-Negative Breast Cancer
by: Raj Kumar
Published: (2025-04-01)

Diagnostic utility of ultrasound features in identifying triple-negative breast cancer
by: Jampana Sahitya, et al.
Published: (2025-05-01)

Translational drugs targeting cancer stem cells in triple-negative breast cancer
by: Felipe P. de Oliveira, et al.
Published: (2025-09-01)

Pathological complete response of locally advanced triple-negative breast cancer: case report
by: V. V. Konstantinova, et al.
Published: (2024-09-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

Results of clinical developments of early triple negative breast cancer drug treatment: ASCO-2022
by: D. A. Andreev, et al.
Published: (2022-11-01)

The role of neoadjuvant chemotherapy of triple-negative breast cancer in St. Petersburg City Clinical Oncological Dispensary
by: A. G. Manikhas, et al.
Published: (2016-09-01)

Cytokeratin expression in breast cancer: from mechanisms, progression, diagnosis, and prognosis to therapeutic implications
by: Ensiyeh Bahadoran, et al.
Published: (2025-12-01)

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
by: Qian Tang, et al.
Published: (2019-12-01)

The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast Cancer: A Multicenter Cross-Sectional Study in Indonesia
by: Jeffry Beta Tenggara, et al.
Published: (2024-01-01)

In Silico Perspectives on Triple Negative Breast Cancer: Challenges and Progress
by: Maham Taqi, et al.
Published: (2025-06-01)

The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience
by: D. A. Enaldieva, et al.
Published: (2023-06-01)

Novel Thymoquinone Derivative TQFL28 Inhibits Triple-Negative Breast Cancer (TNBC) Invasiveness In Vitro and In Vivo
by: Jiayue He, et al.
Published: (2025-06-01)

TOMM40L promotes proliferation and migration of triple negative breast cancer cells and correlates with poor prognosis
by: ZHANG Ke, LU Jiangning, SUN Lixin, YU Long, SUN Lichao, RAN Yuliang
Published: (2025-05-01)

Omitting anthracyclines for the adjuvant treatment of patients with triple-negative breast cancer: A non-inferiority meta-analysis
by: Fabio Girardi, et al.
Published: (2025-10-01)

HEREDITARY BREAST CANCER
by: E. M. Bit-Sava, et al.
Published: (2016-02-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

GGT and GSH-triggered nanoplatform for efficient gambogic acid delivery and tumor penetration in triple-negative breast cancer
by: Su Li, et al.
Published: (2025-08-01)

Chemoimmunomodulation in triple negative breast cancer: a key to maximizing anti-PD-1 chemoimmunotherapeutic efficacy
by: Mohammed O. Gbadamosi, et al.
Published: (2025-12-01)

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer
by: O. O. Gordeeva, et al.
Published: (2020-11-01)

USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stability
by: Pu Wu, et al.
Published: (2025-12-01)

Blood mononuclear cell molecular landscape associated with tumor progression in triple-negative breast cancer
by: M. R. Patysheva, et al.
Published: (2023-11-01)

EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
by: S. G. Smirnova, et al.
Published: (2020-09-01)

Size matters: a review of the challenges in and importance of multimodal approaches to the management of patients with small, node-negative, triple-negative breast cancer
by: Vishnu Prasath, et al.
Published: (2025-07-01)

Effect of body mass index on clinical and morphological characteristics of triple negative breast cancer
by: I. B. Schepotin, et al.
Published: (2014-07-01)

SHCBP1 drives tumor progression in triple-negative breast cancer
by: Huiling Wang, et al.
Published: (2025-07-01)

Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer Cells
by: Ricardo A. León-Letelier, et al.
Published: (2025-06-01)

Molecular genetic predictors of progression of triple negative breast cancer
by: I. S. Panchenko, et al.
Published: (2025-03-01)

Network‐Based Integrative Analysis to Identify Key Genes and Corresponding Reporter Biomolecules for Triple‐Negative Breast Cancer
by: Pooja Singh, et al.
Published: (2025-05-01)

Potentiating Antibody-Dependent Cellular Cytotoxicity in Triple-Negative Breast Cancer via the Humanized Anti-CD147 Antibody
by: Kanyarat Thongheang, et al.
Published: (2025-04-01)

Partial Response Achieved in a Case of Metastatic Triple-Negative Breast Cancer Based on the Patient-Derived Tumor Organoids
by: Liu Y, et al.
Published: (2025-07-01)

Metaplastic carcinoma of the breast: A case series and review of the literature
by: Deniz Eren Böler, et al.
Published: (2016-08-01)

Design and synthesis of 3,4-seco-Lupane triterpene derivatives: targeting tumor angiogenesis and inducing apoptosis in triple-negative breast cancer
by: Chunyu Gao, et al.
Published: (2025-07-01)

A Machine-Learning Model for the Prediction of Triple-Negative Breast Cancer Based on Multiparameter MRI
by: Cai Y, et al.
Published: (2025-07-01)